Science News

Nature Medicine, Published online: 20 October 2026; doi:10.1038/s41591-026-04757-0

Author Correction: FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

Read More